Products
15737 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apple Warrant with ISIN code: CH1467047341 | Apple | Warrant | Put | 220 | 291.625 | 0.28 | 0.010 | 0.29 | 10 | 3.70% | 33.33% | -12.50% | 13 Aug. 2025 | |
| Apple Warrant with ISIN code: CH1467047242 | Apple | Warrant | Put | 200 | 291.625 | 0.006 | ― | ― | 10 | 0.00% | -25.00% | -66.67% | 13 Aug. 2025 | |
| Apple Warrant with ISIN code: CH1467047291 | Apple | Warrant | Put | 200 | 291.625 | 0.068 | ― | ― | 10 | 3.03% | 28.30% | -23.60% | 13 Aug. 2025 | |
| Apple Warrant with ISIN code: CH1467047333 | Apple | Warrant | Put | 200 | 291.625 | 0.17 | ― | ― | 10 | 6.25% | 30.77% | -10.53% | 13 Aug. 2025 | |
| Amgen Mini Future with ISIN code: CH1452869683 | Amgen | Mini Future | Long | 275.61 | 354.517 | 7.27 | 0.010 | 7.28 | 10 | 0.41% | 5.06% | 27.10% | 21 May. 2025 | |
| Amgen Mini Future with ISIN code: CH1114887891 | Amgen | Mini Future | Long | 244.86 | 354.517 | 9.63 | 0.010 | 9.64 | 10 | 0.42% | 3.77% | 20.07% | 2 Jun. 2021 | |
| Amgen Mini Future with ISIN code: CH1146642959 | Amgen | Mini Future | Long | 229.47 | 354.517 | 10.79 | 0.010 | 10.8 | 10 | 0.37% | 3.35% | 17.92% | 22 Nov. 2021 | |
| Amgen Constant Leverage with ISIN code: CH1197222883 | Amgen | Constant Leverage | Long | ― | 354.517 | 0.67 | 0.010 | 0.68 | 1 | -1.47% | 1.52% | 24.07% | 23 Jun. 2022 | |
| Amgen Constant Leverage with ISIN code: CH1396329000 | Amgen | Constant Leverage | Long | ― | 354.517 | 1.06 | 0.010 | 1.07 | 1 | 0.00% | 1.92% | 34.18% | 12 Feb. 2025 | |
| Amgen Constant Leverage with ISIN code: CH1119067564 | Amgen | Constant Leverage | Long | ― | 354.517 | 4.47 | 0.020 | 4.49 | 1 | 0.22% | 3.00% | 22.13% | 10 May. 2022 | |
| Amgen Constant Leverage with ISIN code: CH1119067572 | Amgen | Constant Leverage | Short | ― | 354.517 | 0.1 | 0.010 | 0.11 | 1 | -9.09% | -16.67% | -37.50% | 10 May. 2022 | |
| Amgen Constant Leverage with ISIN code: CH1470667721 | Amgen | Constant Leverage | Short | ― | 354.517 | 6.44 | 0.040 | 6.48 | 1 | -1.38% | -14.36% | ― | 5 Jun. 2026 | |
| Amgen Knock-Out Warrant (open end) with ISIN code: CH1452870897 | Amgen | Knock-Out Warrant (open end) | Call | 276.608 | 354.517 | 6.33 | 0.010 | 6.34 | 10 | 0.48% | 5.85% | 31.60% | 21 May. 2025 | |
| Amgen Knock-Out Warrant (open end) with ISIN code: CH1275969231 | Amgen | Knock-Out Warrant (open end) | Call | 252.003 | 354.517 | 8.36 | 0.010 | 8.37 | 10 | 0.36% | 4.37% | 23.12% | 13 Jun. 2023 | |
| Amgen Knock-Out Warrant (open end) with ISIN code: CH1101793136 | Amgen | Knock-Out Warrant (open end) | Call | 235.287 | 354.517 | 9.67 | 0.010 | 9.68 | 10 | 0.31% | 3.76% | 19.98% | 5 Mar. 2021 | |
| American Express Mini Future with ISIN code: CH1326201170 | American Express | Mini Future | Long | 238.71 | 323.288 | 7.62 | 0.010 | 7.63 | 10 | 5.25% | 14.76% | 10.43% | 13 Feb. 2024 | |
| American Express Mini Future with ISIN code: CH1306083150 | American Express | Mini Future | Long | 193.2 | 323.288 | 11.07 | 0.010 | 11.08 | 10 | 3.55% | 9.71% | 7.79% | 29 Nov. 2023 | |
| American Express Mini Future with ISIN code: CH1496376034 | American Express | Mini Future | Short | 396.42 | 323.288 | 7.48 | 0.010 | 7.49 | 10 | -4.83% | -12.10% | -7.20% | 22 Oct. 2025 | |
| American Express Constant Leverage with ISIN code: CH1345999291 | American Express | Constant Leverage | Long | ― | 323.288 | 2.16 | 0.010 | 2.17 | 1 | 8.54% | 23.43% | 10.77% | 18 Apr. 2024 | |
| American Express Constant Leverage with ISIN code: CH1119067606 | American Express | Constant Leverage | Long | ― | 323.288 | 7.08 | 0.010 | 7.09 | 1 | 5.83% | 15.69% | 9.26% | 10 May. 2022 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.